Financial report interval: 2025.12.30 - 2026.06.30
Overview: 3SBIO(01530) the Revenue is 5.224 B (+9.57%), Miss estimate;the EBIT is 1.779 B (+30.74%), Miss estimate;the EPS is 0.508 (-17.15%), Miss estimate.